HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
about
Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patientsAssociation of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markersUncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme.Viral hepatitis in HIV infection.Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.Liver disease in the HIV-infected individual.Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected personsEffect of anemia on hepatotoxicity of HAART in HIV patients in Benin cityHepatic Enzyme Alterations in HIV Patients on Antiretroviral Therapy: A Case-Control Study in a Hospital Setting in GhanaHepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.Liver Enzymes Abnormalities among Highly Active Antiretroviral Therapy Experienced and HAART Naïve HIV-1 Infected Patients at Debre Tabor Hospital, North West Ethiopia: A Comparative Cross-Sectional Study.Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.Liver steatosis in Chinese HIV-infected patients with hypertriglyceridemia: characteristics and independent risk factorsThe prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfectionsHigh prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection.Syphilitic hepatitis among HIV-infected patients.Correlation between HIV viral load and aminotransferases as liver damage markers in HIV infected naive patients: a concordance cross-sectional study.Nonalcoholic fatty liver disease among HIV-infected persons.The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.Liver Fibrosis and Hepatitis B Coinfection among ART Naïve HIV-Infected Patients at a Tertiary Level Hospital in Northwestern Tanzania: A Cross-Sectional StudyLiver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.A cross-sectional study of liver function tests in HIV-infected persons in Western India.Changing clinical profile and factors associated with liver enzyme abnormalities among HIV-infected persons.Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.Prevalence and predictors of liver disease in HIV-infected children and adolescents.Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.Hepatic ultrastructural mitochondrial changes prior to antiretroviral therapy in HIV-infected patients in Brazil.Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy.A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UKHepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
P2860
Q28472348-543524EA-87D9-498E-B6C9-F5598CAFD074Q30387567-07BEC8D4-74C6-4F0E-8EFF-CAB469221ADBQ33621724-9C2E44B1-F7A3-4F19-B0C8-3DB56EFCC4E9Q33947453-C780676A-DAD1-4E77-BD44-E228334E8907Q34086980-E7858651-58AB-4CA1-B5DB-885DF966B135Q34209648-8EE1BC9C-C74B-4410-BAB2-E1AC6C9317AAQ34380326-5522752E-AD40-48AF-8C99-3EA93D0C9B09Q34973371-53E6C268-54D9-45CF-A8BF-AA73CC922012Q35000898-3B799A30-6C1B-49DC-81B3-AC585360AF92Q35062602-1E83EBF2-19DE-40AF-AD23-8D00A26FB472Q35542957-2F7F81D1-AA3D-44DB-A1EA-A2E18DAE0D73Q35738818-422AA1CE-E1ED-4B8E-9839-C996C435E651Q36532400-BF6223EA-5F63-4527-B2F5-98DC8F1F9896Q36672577-A254AE81-C4C1-4ADA-8E4E-BF2815F8DD8BQ37132172-646D9507-1A5C-4255-8105-245E0B36538CQ37149701-FEC0D72F-366C-4756-84A3-8BD6AA193459Q37152712-10F12E65-DBE9-40E0-8902-9F183573DCB4Q37332151-EF6DE7F7-8898-4053-94D9-D4150234A569Q37339807-1E20695A-319C-4427-A16B-06CEA90133DDQ37366079-F43BC986-70FD-44C6-9DAF-612F741C8DF4Q37420583-49EB1D0C-3F6A-41DF-B9AE-D36D71E04DE8Q37434578-B5730764-4BFB-4B15-8D04-05B092E81687Q37662407-B40EB992-5B06-4E5F-B239-8050EFCFCE32Q38615081-A5CA8A7E-A75F-4EB3-8385-6CAC524BF713Q40271245-B37EA019-33C6-47BF-A12C-D0EB3E954945Q40357994-F3615BAF-F8F4-429F-A618-A0168309B913Q40637208-F33E6D69-7090-41DF-ACDA-D59AA19147DBQ40797865-E6203D0B-2479-4A6B-9998-7B17867F0558Q41822943-42929B0A-9024-4F58-9DAA-9761E50A5E4BQ41929658-F498E3D2-CB15-48E3-B88F-CE0801E78EC4Q42274735-79BE70E2-C962-4BBB-A646-83107AB822D5Q44174121-30432B2C-A780-460A-AE9D-3152C75CFEC1Q46484648-6E4C6E51-6741-4F5E-85EB-4DB5729217BEQ46907929-74EA0D9A-91B5-4F0C-8C9D-ADCE531942A1Q48439926-6521F6CC-AC98-4A5D-B1A3-D6AE3DDD9DFCQ56762706-686E06CA-DD47-4851-9085-A0B9AB854369Q56920945-5E2CC76C-6DE9-406D-A875-08B92DDDA215
P2860
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@en
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@nl
type
label
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@en
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@nl
prefLabel
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@en
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@nl
P356
P1476
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
@en
P2093
Anais Vallet-Pichard
Pascal Lebray
P304
P356
10.1086/381499
P407
P478
38 Suppl 2
P577
2004-03-01T00:00:00Z